A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
GU003 is closed to accrual effective July 9, 2018. All patients registered to Step 1 registration by July 9, 2018, will be permitted to proceed to the randomization step (Step 2).
